NCT01964339View on ClinicalTrials.gov

Obesity Hypoventilation Syndrome Prevalence Study

TerminatedOBSERVATIONAL
Enrollment

44

Participants

Timeline

Start Date

October 9, 2013

Primary Completion Date

May 21, 2014

Study Completion Date

May 21, 2014

Conditions
Obesity Hypoventilation Syndrome
Interventions
OTHER

BMI greater than or equal to 30kg/m2 scheduled for PSG. Undergo blood draw (venous blood gas and metabolic panel) and data collection from PSG study.

Venous blood gas, basic metabolic panel, PSG variable data collection.

OTHER

BMI greater than or equal to 30kg/m2 scheduled for PSG. Undergo blood draw (arterial blood gas and metabolic panel) and data collection from PSG study.

Arterial blood gas, basic metabolic panel, PSG variable data collection

Trial Locations (1)

70115

Ochsner Baptist Medical Center, New Orleans

Sponsors
All Listed Sponsors
lead

Philips Respironics

INDUSTRY

NCT01964339 - Obesity Hypoventilation Syndrome Prevalence Study | Biotech Hunter | Biotech Hunter